The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?

被引：0
|
作者：
Kantarjian, Hagop M. [1 ]
O'Brien, Susan [2 ]
Ravandi, Farhad [2 ]
Borthakur, Gautam [2 ]
Faderl, Stefan [2 ]
Bueso-Ramos, Carlos [2 ]
Abruzzo, Lynne [2 ]
Pierce, Sherry [2 ]
Shan, Jianqin [2 ]
Issa, Jean-Pierre [2 ]
Garcia-Manero, Guillermo [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [31] DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE
    Gerds, A. T.
    List, A. F.
    Giagounidis, A.
    Hellstrom-Lindberg, E.
    Li, J. Shiansong
    Swern, A. S.
    Sugrue, M. M.
    Fenaux, P.
    Sekeres, M. A.
    LEUKEMIA RESEARCH, 2015, 39 : S109 - S109
  • [32] Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013) in patients with transfusion-dependent (TD) myelodysplastic syndrome (MDS) and chromosome 5q31.1 deletion: Results of the multicenter MDS-003 study.
    List, AF
    Dewald, G
    Bennett, J
    Giagounadis, A
    Raza, A
    Feldman, E
    Powell, B
    Greenberg, P
    Zeldis, J
    Knight, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 2S - 2S
  • [33] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    DiNardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 945 - 946
  • [34] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    Di Nardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 945 - 946
  • [35] Does marrow fibrosis influence post-transplant outcome in patients with myelodysplastic syndrome (MDS)?
    Scott, BL
    Chyou, F
    Deeg, HJ
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 47 - 48
  • [36] Incidence, Treatment and Course Of Disease Of Patients With del5q Myelodysplastic Syndrome (MDS) In The "pre-lenalidomide" Era In Germany. Data From The German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Snide
    Sauer, Annette
    Linck, Dominick
    Severin, Kai
    Germing, Ulrich
    Gattermann, Norbert
    Schmitz, Stephan
    BLOOD, 2013, 122 (21)
  • [37] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    LABORATORY INVESTIGATION, 2005, 85 : 223A - 224A
  • [38] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    MODERN PATHOLOGY, 2005, 18 : 223A - 224A
  • [39] Prevalence and Impact on Outcomes of Additional Karyotypic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Del(5q) from the MDS-003 and MDS-004 Studies
    Giagounidis, Aristoteles
    List, Alan F.
    Hellstroem-Lindberg, Eva
    Mufti, Ghulam J.
    Schlegelberger, Brigitte
    Morrill, John
    Wu, Chengqing
    Skikne, Barry S.
    Fenaux, Pierre
    Goehring, Gudrun
    BLOOD, 2015, 126 (23)
  • [40] Prevalence and Clinical Impact of Additional Cytogenetic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Deletion 5q from the MDS-003 and MDS-004 Studies
    Giagounidis, Aristoteles
    List, Alan F.
    Hellstrom-Lindberg, Eva
    Mufti, Ghulam J.
    Schlegelberger, Brigitte
    Morrill, John
    Wu, Chengqing
    Skikne, Barry
    Fenaux, Pierre
    Goehring, Gudrun
    BLOOD, 2014, 124 (21)
12345